Literature DB >> 19786154

Hypertension in pregnancy and women of childbearing age.

Scott R Yoder1, Loralei L Thornburg, John D Bisognano.   

Abstract

Hypertension in women of childbearing age is a challenging medical problem with increasing prevalence. Essential hypertension remains the most common diagnosis in young women. Reproductive goals and possible teratogenic effects must be considered when initiating therapy. Hypertensive disorders of pregnancy are frequent causes of maternal/fetal morbidity and mortality, the most common being preeclampsia/eclampsia. Pregnant patients should be screened routinely. Early recognition and prompt care from a multidisciplinary service, including obstetrics, cardiology, and intensive medicine, are required to prevent deleterious outcomes. Hypertensive disorders of pregnancy reflect endometrial endothelial dysfunction/abnormalities and systemic endothelial dysfunction, which might predict future cardiovascular disease in these young women, prompting early preventive measures.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19786154     DOI: 10.1016/j.amjmed.2009.03.036

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  41 in total

1.  Ambient air pollution and hypertensive disorder of pregnancy.

Authors:  Xiaohui Xu; Hui Hu; Sandie Ha; Jeffrey Roth
Journal:  J Epidemiol Community Health       Date:  2013-09-10       Impact factor: 3.710

2.  Ambient Air Pollution and Risk of Gestational Hypertension.

Authors:  Yeyi Zhu; Cuilin Zhang; Danping Liu; Sandie Ha; Sung Soo Kim; Anna Pollack; Pauline Mendola
Journal:  Am J Epidemiol       Date:  2017-08-01       Impact factor: 4.897

3.  Taking angiotensin-converting enzyme inhibitors during pregnancy: is it safe?

Authors:  Almundher Al-Maawali; Asnat Walfisch; Gideon Koren
Journal:  Can Fam Physician       Date:  2012-01       Impact factor: 3.275

4.  Adverse Effects of Exposure to Fine Particulate Matters and Ozone on Gestational Hypertension.

Authors:  Rong Yang; Dan Luo; Yi-Ming Zhang; Ke Hu; Zheng-Min Qian; Li-Qin Hu; Long-Jiao Shen; Hong Xian; Juliet Iwelunmor; Su-Rong Mei
Journal:  Curr Med Sci       Date:  2019-12-16

5.  Pharmacotherapy and pregnancy: highlights from the Third International Conference for Individualized Pharmacotherapy in Pregnancy.

Authors:  David M Haas; Beverly Gallauresi; Kristine Shields; Deborah Zeitlin; Shannon M Clark; Mary F Hebert; Zhaoxia Ren; Srikanth C Nallani; Eric M Meslin; Karen B Feibus; Gideon Koren; W Scott Goebel; Thomas Easterling; Scott C Denne; David A Flockhart; Jamie L Renbarger
Journal:  Clin Transl Sci       Date:  2011-06       Impact factor: 4.689

Review 6.  Guided imagery for treating hypertension in pregnancy.

Authors:  Megumi Haruna; Masayo Matsuzaki; Erika Ota; Mie Shiraishi; Nobutsugu Hanada; Rintaro Mori
Journal:  Cochrane Database Syst Rev       Date:  2019-04-27

7.  Exposure to candesartan during the first trimester of pregnancy in type 1 diabetes: experience from the placebo-controlled DIabetic REtinopathy Candesartan Trials.

Authors:  M Porta; J W Hainer; S-O Jansson; A Malm; R Bilous; N Chaturvedi; J H Fuller; R Klein; T Orchard; H-H Parving; A-K Sjølie
Journal:  Diabetologia       Date:  2011-01-12       Impact factor: 10.122

8.  Maternal ethnicity and pre-eclampsia in New York City, 1995-2003.

Authors:  Jian Gong; David A Savitz; Cheryl R Stein; Stephanie M Engel
Journal:  Paediatr Perinat Epidemiol       Date:  2011-08-01       Impact factor: 3.980

9.  Ozone and hypertensive disorders of pregnancy in Florida: Identifying critical windows of exposure.

Authors:  Hui Hu; Sandie Ha; Xiaohui Xu
Journal:  Environ Res       Date:  2016-12-08       Impact factor: 6.498

10.  Combination therapy in hypertension: An update.

Authors:  Sanjay Kalra; Bharti Kalra; Navneet Agrawal
Journal:  Diabetol Metab Syndr       Date:  2010-06-24       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.